A problem-solving education intervention in caregivers and patients during allogeneic hematopoietic stem cell transplantation

Bevans, Margaret; Wehrlen, Leslie; Castro, Kathleen; Prince, Patricia; Shelburne, Nonniekaye; Soeken, Karen L.; Zabora, James; Wallen, Gwenyth R.

doi:10.1177/1359105313475902

Cited by 61 publications

(65 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A "dose-response" of behavior changes according to the number of educational modules received has been reported in other behavior interventions similar to the MPP. [43][44][45] The MPP effectiveness in reducing HF outcomes is also consistent with other educational intervention studies in which intervention "compliance" has an important role in determining efficacy.…”

Section: %supporting

confidence: 79%

“…Many studies have found a "dose effect" with educational interventions for disease management in which the number of lessons received or attended was associated with better clinical outcomes. [43][44][45] This is especially important for severe and complicated medical conditions, such as HF, in which it is important that patients learn about and manage all aspects related to their medical condition (e.g., complex medication regime, drastic sodium reduction in diet, and reducing edema). A "dose-response" of behavior changes according to the number of educational modules received has been reported in other behavior interventions similar to the MPP.…”

Section: %mentioning

confidence: 99%

See 1 more Smart Citation

A randomized controlled trial to improve heart failure disparities: the Mālama Puʻuwai (caring for heart) Study

Mau¹,

Lim²,

Kaholokula³

et al. 2017

OAJCT

View full text Add to dashboard Cite

Objective/Background: To conduct a randomized controlled trial to test the efficacy of a culturally tailored heart failure (HF) education program, to reduce HF hospital readmissions and/or cardiovascular disease death (HF outcomes) among Native Hawaiian and Other Pacific Islander (NHOPI) patients with HF. Methods: One hundred fifty HF patients aged ≥21 years, NHOPI race, and discharged to home were enrolled and randomized to the Mālama Puʻuwai Program (MPP) or the usual care (UC). The MPP group received a culturally tailored HF program, and the UC received similar standard HF education materials. Clinical and health behavior data were measured at baseline and 12 months. HF outcomes were monitored throughout the entire study period. Two-sample t-test, chi-square, and Cox proportional hazard modeling assessed the efficacy of intervention (MPP or UC) on HF outcomes using an intention-to-treat approach. A sensitivity post hoc analysis was performed on patients who completed the full intervention (n=127). Results: Overall, 69% were men, mean age 54.4±13.4 years, 62% were Native Hawaiian, and 24% reported methamphetamine use. More UC participants reported methamphetamine use (32% vs. 16%), hypertension (81% vs. 63%), but less myocardial infarction (27% vs. 48%). HF outcomes were higher in UC (31%) compared with MPP (19%) with higher risk for HF outcomes (hazard ratio [HR] 1.74; 95% CI: 0.89-3.40). Sensitivity post hoc analysis of intervention compliance revealed that UC was at significantly higher risk for HF outcomes than MPP (HR 2.83; 95% CI: 1.19-6.72). Conclusions: Culturally tailored HF programs have the potential to reduce HF outcomes among compliant minority patients with HF such as NHOPI.

show abstract

Section: %supporting

confidence: 79%

Section: %mentioning

confidence: 99%

A randomized controlled trial to improve heart failure disparities: the Mālama Puʻuwai (caring for heart) Study

Mau¹,

Lim²,

Kaholokula³

et al. 2017

OAJCT

View full text Add to dashboard Cite

show abstract

“…Limited interventions such as education, psychosocial support, and self-care for the family caregivers of HSCT recipients have been reported (Gemmill et al, 2011). Recently, it has been showed that caregivers participating in a problem-solving form of education during HSCT period increased their self-efficacy and they had reduced symptoms distress (Bevans et al, 2014). Because the family member has the highest distress in pre-transplant period (Beattie and Lebel, 2011) we suggest that they would benefit from more targeted support during this phase, to boost them to prevent and handle the uncertainty during the HSCT.…”

Section: Discussionmentioning

confidence: 84%

Family members’ life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative study

et al. 2016

View full text Add to dashboard Cite

The aim of this study was to describe family members’ life situation and experiences of care in two different care settings, the patient's home or in hospital during the acute post‐transplantation phase after allogeneic haematopoietic stem cell transplantation (HSCT). Data were collected through semi‐structured interviews with 14 family members (seven women and seven men). An inductive qualitative content analysis was used to analyse the data. The majority of the family members’ (n = 10) had experiences from home care. The findings show the family members’ voice of the uncertainty in different ways, related with the unknown prognosis of the HSCT, presented as Being me being us in an uncertain time. The data are classified into; To meet a caring organisation, To be in different care settings, To be a family member and To have a caring relationship. Positive experiences such as freedom and security from home care were identified. The competence and support from the healthcare professionals was profound. Different strategies such as adjusting, having hope and live in the present used to balance to live in an uncertain time. The healthcare professionals need to identify psychosocial problems, and integrate the psychosocial support for the family to alleviate or decrease anxiety during HSCT, regardless of the care setting.

show abstract

“…With these points in mind, comprehensive long-term follow-up units aimed specifically at alloHCT survivors have shown evidence of efficacy [119•]. Interventions for caregivers may similarly ease the burdens of alloHCT survivorship [127,128].…”

Section: Othermentioning

confidence: 99%

A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies

Luskin

Banerjee

Percio

et al. 2015

Curr Hematol Malig Rep

View full text Add to dashboard Cite

Patients treated for a hematologic malignancy are at risk for treatment-related complications. As the goal of therapy is frequently curative, treatments are especially intensive and long-term toxicity is common. Chemotherapy and radiation are associated with increased risk for cardiac and pulmonary disease, endocrine disorders, infertility, sexual dysfunction, second cancers, and psychosocial distress. The risk for each complication is dictated by patient characteristics including age, co-morbidities, and genetic predispositions, as well as the specifics of therapy. Survivors of pediatric cancers and allogeneic hematopoietic stem cell transplantation have unique risks due to vulnerable age at time of toxic exposure and ongoing immune dysfunction, respectively.

show abstract

A problem-solving education intervention in caregivers and patients during allogeneic hematopoietic stem cell transplantation

Cited by 61 publications

References 48 publications

A randomized controlled trial to improve heart failure disparities: the Mālama Puʻuwai (caring for heart) Study

A randomized controlled trial to improve heart failure disparities: the Mālama Puʻuwai (caring for heart) Study

Family members’ life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative study

A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies

Contact Info

Product

Resources

About